Barclays’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Sell
66,800
-234,988
-78% -$1.22M ﹤0.01% 3472
2025
Q4
$1.86M Buy
301,788
+12,591
+4% +$91.3K ﹤0.01% 2989
2025
Q3
$2.09M Sell
289,197
-57,462
-17% -$341K ﹤0.01% 2858
2025
Q2
$1.84M Buy
346,659
+170,779
+97% +$1.01M ﹤0.01% 2908
2025
Q1
$1.56M Sell
175,880
-28,171
-14% -$338K ﹤0.01% 2819
2024
Q4
$2.8M Buy
204,051
+13,808
+7% +$255K ﹤0.01% 2648
2024
Q3
$5.21M Buy
190,243
+109,931
+137% +$2.98M ﹤0.01% 2062
2024
Q2
$1.96M Sell
80,312
-64,767
-45% -$1.42M ﹤0.01% 2165
2024
Q1
$3.09M Sell
145,079
-54,116
-27% -$1.16M ﹤0.01% 2202
2023
Q4
$3.81M Buy
199,195
+56,823
+40% +$983K ﹤0.01% 2358
2023
Q3
$2.28M Buy
142,372
+13,068
+10% +$249K ﹤0.01% 1813
2023
Q2
$3M Buy
129,304
+24,794
+24% +$541K ﹤0.01% 1634
2023
Q1
$2.43M Sell
104,510
-36,937
-26% -$750K ﹤0.01% 2047
2022
Q4
$2.05M Buy
141,447
+7,203
+5% +$134K ﹤0.01% 2252
2022
Q3
$2.56M Buy
134,244
+100,291
+295% +$2.3M ﹤0.01% 1581
2022
Q2
$617K Sell
33,953
-37,062
-52% -$770K ﹤0.01% 2712
2022
Q1
$1.79M Sell
71,015
-42,698
-38% -$1.09M ﹤0.01% 1951
2021
Q4
$3.14M Buy
113,713
+11,289
+11% +$327K ﹤0.01% 2061
2021
Q3
$3.31M Buy
102,424
+56,376
+122% +$1.87M ﹤0.01% 1929
2021
Q2
$1.41M Sell
46,048
-47,437
-51% -$1.37M ﹤0.01% 2432
2021
Q1
$2.85M Buy
93,485
+7,295
+8% +$207K ﹤0.01% 1985
2020
Q4
$1.7M Sell
86,190
-68,401
-44% -$1.1M ﹤0.01% 2364
2020
Q3
$2.02M Buy
154,591
+83,442
+117% +$1.06M ﹤0.01% 2098
2020
Q2
$807K Sell
71,149
-125,948
-64% -$1.79M ﹤0.01% 2946
2020
Q1
$2.82M Sell
197,097
-202,150
-51% -$4.27M ﹤0.01% 1964
2019
Q4
$10.9M Buy
399,247
+326,653
+450% +$8.99M 0.01% 1338
2019
Q3
$2.08M Sell
72,594
-45,061
-38% -$1.31M ﹤0.01% 2816
2019
Q2
$3.27M Buy
117,655
+69,909
+146% +$1.97M ﹤0.01% 2328
2019
Q1
$1.58M Buy
47,746
+17,953
+60% +$547K ﹤0.01% 2845
2018
Q4
$866K Sell
29,793
-69,048
-70% -$2.48M ﹤0.01% 3268
2018
Q3
$4.55M Buy
98,841
+62,660
+173% +$2.79M 0.01% 1908
2018
Q2
$1.35M Sell
36,181
-45,427
-56% -$1.53M ﹤0.01% 2947
2018
Q1
$2.41M Buy
81,608
+16,268
+25% +$550K ﹤0.01% 2290
2017
Q4
$2.24M Sell
65,340
-24,767
-27% -$836K ﹤0.01% 2324
2017
Q3
$3.26M Sell
90,107
-33,776
-27% -$963K 0.01% 1873
2017
Q2
$3.2M Buy
123,883
+22,304
+22% +$473K 0.01% 1822
2017
Q1
$1.95M Sell
101,579
-13,678
-12% -$242K ﹤0.01% 2129
2016
Q4
$1.92M Buy
115,257
+8,273
+8% +$150K 0.01% 2159
2016
Q3
$2.2M Buy
106,984
+92,161
+622% +$2.34M 0.01% 1925
2016
Q2
$454K Buy
14,823
+6,371
+75% +$221K ﹤0.01% 3292
2016
Q1
$313K Buy
8,452
+5,135
+155% +$193K ﹤0.01% 3517
2015
Q4
$143K Sell
3,317
-26,945
-89% -$1.14M ﹤0.01% 4160
2015
Q3
$1.12M Sell
30,262
-21,048
-41% -$747K ﹤0.01% 2606
2015
Q2
$1.69M Sell
51,310
-109,711
-68% -$3.73M ﹤0.01% 2372
2015
Q1
$5.63M Buy
161,021
+79,501
+98% +$2.85M 0.01% 1470
2014
Q4
$2.77M Buy
81,520
+44,141
+118% +$1.57M 0.01% 2235
2014
Q3
$1.42M Buy
37,379
+11,403
+44% +$425K ﹤0.01% 2987
2014
Q2
$986K Buy
25,976
+510
+2% +$19K ﹤0.01% 3351
2014
Q1
$866K Sell
25,466
-126,953
-83% -$3.93M ﹤0.01% 3392
2013
Q4
$3.05M Buy
152,419
+101,888
+202% +$2.58M 0.01% 2249
2013
Q3
$1.16M Buy
50,531
+41,783
+478% +$1.19M ﹤0.01% 3189
2013
Q2
$235K Buy
+8,748
New +$254K ﹤0.01% 5012

Other funds holding MYGN